{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:44:24Z","timestamp":1773675864303,"version":"3.50.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1097\/inf.0000000000001276","type":"journal-article","created":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T16:29:09Z","timestamp":1465662549000},"page":"1225-1228","source":"Crossref","is-referenced-by-count":3,"title":["Universal Antiretroviral Treatment Eligibility for Children and Adolescents Living With HIV"],"prefix":"10.1097","volume":"35","author":[{"given":"Eric J.","family":"Dziuban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia D.","family":"Rivadeneira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-15-20210202","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa0800971","article-title":"Early antiretroviral therapy and mortality among HIV-infected infants.","volume":"359","author":"Violari","year":"2008","journal-title":"N Engl J Med"},{"key":"R3-15-20210202","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1097\/QAD.0000000000000095","article-title":"Linkage, initiation and retention of children in the antiretroviral therapy cascade: an overview.","volume":"27","author":"Phelps","year":"2013","journal-title":"AIDS"},{"key":"R10-15-20210202","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV infection.","volume":"373","author":"Lundgren","year":"2015","journal-title":"N Engl J Med"},{"key":"R11-15-20210202","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa1507198","article-title":"A trial of early antiretrovirals and isoniazid preventive therapy in Africa.","volume":"373","author":"Danel","year":"2015","journal-title":"N Engl J Med"},{"key":"R12-15-20210202","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy.","volume":"365","author":"Cohen","year":"2011","journal-title":"N Engl J Med"},{"key":"R13-15-20210202","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/COH.0000000000000027","article-title":"Immediate antiretroviral therapy in young HIV-infected children: benefits and risks.","volume":"9","author":"Collins","year":"2014","journal-title":"Curr Opin HIV AIDS"},{"key":"R14-15-20210202","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1097\/INF.0000000000000662","article-title":"Starting treatment in pediatric HIV infection: try to clarify a gray area.","volume":"34","author":"Prato","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R15-15-20210202","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/INF.0b013e318253844b","article-title":"Impact of HIV severity on cognitive and adaptive functioning during childhood and adolescence.","volume":"31","author":"Smith","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R16-15-20210202","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/09540121.2013.841828","article-title":"The neurodevelopment of HIV-infected infants on HAART compared to HIV-exposed but uninfected infants.","volume":"26","author":"Whitehead","year":"2014","journal-title":"AIDS Care"},{"key":"R17-15-20210202","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1097\/QAD.0b013e32832dc041","article-title":"Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents.","volume":"23","author":"Patel","year":"2009","journal-title":"AIDS"},{"key":"R18-15-20210202","doi-asserted-by":"crossref","first-page":"e1326","DOI":"10.1542\/peds.2012-0405","article-title":"Neurodevelopment in children born to HIV-infected mothers by infection and treatment status.","volume":"130","author":"Le Doar\u00e9","year":"2012","journal-title":"Pediatrics"},{"key":"R19-15-20210202","doi-asserted-by":"crossref","first-page":"18603","DOI":"10.7448\/IAS.16.1.18603","article-title":"Neurodevelopment in perinatally HIV-infected children: a concern for adolescence.","volume":"16","author":"Laughton","year":"2013","journal-title":"J Int AIDS Soc"},{"key":"R20-15-20210202","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/QAD.0000000000000766","article-title":"White matter micro-structural changes in ART-naive and ART-treated children and adolescents infected with HIV in South Africa.","volume":"29","author":"Hoare","year":"2015","journal-title":"AIDS"},{"key":"R21-15-20210202","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2431-11-11","article-title":"The motor development of orphaned children with and without HIV: pilot exploration of foster care and residential placement.","volume":"11","author":"Jelsma","year":"2011","journal-title":"BMC Pediatr"},{"key":"R22-15-20210202","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.childyouth.2014.03.040","article-title":"Developmental challenges in HIV infected children\u2014an updated systematic review.","volume":"45","author":"Sherr","year":"2014","journal-title":"Child Youth Serv Rev"},{"key":"R23-15-20210202","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/INF.0b013e31827fb19d","article-title":"Cognitive function and neurodevelopmental outcomes in HIV-infected children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental study.","volume":"32","author":"Puthanakit","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R24-15-20210202","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S1473-3099(12)70242-6","article-title":"Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial.","volume":"12","author":"Puthanakit","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"R25-15-20210202","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/QAD.0000000000000590","article-title":"Pubertal development in HIV-infected African children on first-line antiretroviral therapy.","volume":"29","author":"Szubert","year":"2015","journal-title":"AIDS"},{"key":"R26-15-20210202","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/QAD.0b013e328361195b","article-title":"Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatment.","volume":"27","author":"Williams","year":"2013","journal-title":"AIDS"},{"key":"R27-15-20210202","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/jamapediatrics.2013.1206","article-title":"Cardiac status of children infected with human immunodeficiency virus who are receiving long-term combination antiretroviral therapy: results from the Adolescent Master Protocol of the Multicenter Pediatric HIV\/AIDS Cohort Study.","volume":"167","author":"Lipshultz","year":"2013","journal-title":"JAMA Pediatr"},{"key":"R28-15-20210202","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/cid\/cis271","article-title":"Chronic lung disease in adolescents with delayed diagnosis of vertically acquired HIV infection.","volume":"55","author":"Ferrand","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R29-15-20210202","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2431-10-56","article-title":"Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study.","volume":"10","author":"Musoke","year":"2010","journal-title":"BMC Pediatr"},{"key":"R30-15-20210202","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1365-3156.2010.02561.x","article-title":"Growth response to antiretroviral treatment in HIV-infected children: a cohort study from Lilongwe, Malawi.","volume":"15","author":"Weigel","year":"2010","journal-title":"Trop Med Int Health"},{"key":"R31-15-20210202","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2334-11-54","article-title":"Weight and height z-scores improve after initiating ART among HIV-infected children in rural Zambia: a cohort study.","volume":"11","author":"Sutcliffe","year":"2011","journal-title":"BMC Infect Dis"},{"key":"R32-15-20210202","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/infdis\/jiu099","article-title":"Epstein-Barr virus load in children infected with human immunodeficiency virus type 1 in Uganda.","volume":"210","author":"Petrara","year":"2014","journal-title":"J Infect Dis"},{"key":"R33-15-20210202","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/irv.12243","article-title":"HIV virological suppression influences response to the AS03-adjuvanted monovalent pandemic influenza A H1N1 vaccine in HIV-infected children.","volume":"8","author":"Leahy","year":"2014","journal-title":"Influenza Other Respir Viruses"},{"key":"R34-15-20210202","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/infdis\/jir787","article-title":"Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution.","volume":"205","author":"Lewis","year":"2012","journal-title":"J Infect Dis"},{"key":"R35-15-20210202","doi-asserted-by":"crossref","first-page":"e1001542","DOI":"10.1371\/journal.pmed.1001542","article-title":"Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study.","volume":"10","author":"Picat","year":"2013","journal-title":"PLoS Med"},{"key":"R37-15-20210202","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/13548506.2014.945601","article-title":"A systematic review of treatment fatigue among HIV-infected patients prescribed antiretroviral therapy.","volume":"20","author":"Claborn","year":"2015","journal-title":"Psychol Health Med"},{"key":"R39-15-20210202","doi-asserted-by":"crossref","first-page":"17383","DOI":"10.7448\/IAS.15.2.17383","article-title":"Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review.","volume":"15","author":"Kranzer","year":"2012","journal-title":"J Int AIDS Soc"},{"key":"R40-15-20210202","first-page":"148","article-title":"Impact of an innovative approach to prevent mother-to-child transmission of HIV-Malawi, July 2011-September 2012.","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R41-15-20210202","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/tmi.12142","article-title":"Paediatric HIV care in sub-Saharan Africa: clinical presentation and 2-year outcomes stratified by age group.","volume":"18","author":"Ben-Farhat","year":"2013","journal-title":"Trop Med Int Health"},{"key":"R42-15-20210202","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-3156.2010.02503.x","article-title":"Outcome assessment of decentralization of antiretroviral therapy provision in a rural district of Malawi using an integrated primary care model.","volume":"15","author":"Chan","year":"2010","journal-title":"Trop Med Int Health"},{"key":"R43-15-20210202","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/QAD.0000000000000054","article-title":"High attrition before and after ART initiation among youth (15-24 years of age) enrolled in HIV care.","volume":"28","author":"Lamb","year":"2014","journal-title":"AIDS"},{"key":"R44-15-20210202","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1097\/QAI.0b013e318278bcb0","article-title":"Retention of HIV-infected children on antiretroviral treatment in HIV care and treatment programs in Kenya, Mozambique, Rwanda, and Tanzania.","volume":"62","author":"McNairy","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R45-15-20210202","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1097\/QAD.0b013e32836149ea","article-title":"HIV-infected adolescents in southern Africa can achieve good treatment outcomes: results from a retrospective cohort study.","volume":"27","author":"Shroufi","year":"2013","journal-title":"AIDS"},{"key":"R46-15-20210202","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/QAD.0000000000000082","article-title":"Predicted levels of HIV drug resistance: potential impact of expanding diagnosis, retention, and eligibility criteria for antiretroviral therapy initiation.","volume":"28","author":"Cambiano","year":"2014","journal-title":"AIDS"},{"key":"R48-15-20210202","doi-asserted-by":"crossref","first-page":"e74568","DOI":"10.1371\/journal.pone.0074568","article-title":"HIV-infected adolescent mothers and their infants: low coverage of HIV services and high risk of HIV transmission in KwaZulu-Natal, South Africa.","volume":"8","author":"Horwood","year":"2013","journal-title":"PLoS One"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000001276","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:11:53Z","timestamp":1620954713000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201611000-00015"}},"subtitle":["A New Era"],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001276","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}